Marubeni Corp.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 6.96 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2023.
Marubeni Corp.'s second quarter result of 1.78 Trillion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents a decrease of -4.39 percent compared to it's first quarter result.
Also, Marubeni Corp.'s second quarter result of 1.78 Trillion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 13.00 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Marubeni Corp.'s second quarter result of 6.96 Trillion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 3.03 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.88 percent compared to the value the year prior.
The 1 year change in percent is 10.88.
The 3 year change in percent is -22.30.
The 5 year change in percent is 25.43.
The 10 year change in percent is 0.6383.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Cost of Goods Sold Including Depreciation and Amortization | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Cost of Goods Sold Including Depreciation and Amortization | 186,696,990,720.00 |
![]() | BlackRock Inc - Cost of Goods Sold Including Depreciation and Amortization | 166,346,604,544.00 |
![]() | KKR & Co LP - Cost of Goods Sold Including Depreciation and Amortization | 119,832,821,760.00 |
![]() | BioPharma Credit PLC - Cost of Goods Sold Including Depreciation and Amortization | 101,856,345,600.00 |